- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Nexalin Technology beschließt Reverse-Aktiensplit im Verhältnis 1:30 | 3 | Investing.com Deutsch | ||
| Do | Nexalin Technology approves 1-for-30 reverse stock split | 3 | Investing.com | ||
| Do | Nexalin Technology announces 1-for-30 reverse stock split | 2 | Seeking Alpha | ||
| Do | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Do | Nexalin Technology, Inc.: Nexalin Technology Announces Reverse Stock Split | 307 | GlobeNewswire (Europe) | HOUSTON, TX, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), announces that its board of directors has approved a 1-for-30 reverse stock split... ► Artikel lesen | |
| 17.08. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08. | Nexalin Technology, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 27.07. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.06. | Nexalin Technology, Inc.: Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company's Proprietary DIFS Platform | 1 | GlobeNewswire (USA) | ||
| 17.06. | Nexalin Technology, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.06. | Nexalin Technology, Inc.: Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life ... | 264 | GlobeNewswire (Europe) | Study using Nexalin's proprietary DIFS 15 mA 77.5 Hz treatment platform demonstrated rapid, large-magnitude improvements in anxiety and depression with benefits maintained at 8-week follow-up Results... ► Artikel lesen | |
| 10.06. | EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life | 2 | Benzinga.com | ||
| 04.06. | Nexalin receives U.S. patent for neurostimulation method | 1 | Investing.com | ||
| 04.06. | Nexalin erhält US-Patent für Neurostimulationsverfahren gegen Angst, Depression und Schlaflosigkeit | 1 | Investing.com Deutsch | ||
| 04.06. | Nexalin Technology, Inc.: Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia | 245 | GlobeNewswire (Europe) | Newly issued U.S. patent expected to provide core intellectual property protection through 2042, further strengthening Nexalin's proprietary position in non-invasive frequency-based deep-brain neurostimulation... ► Artikel lesen | |
| 27.05. | Nexalin Technology: EPS übertrifft Schätzungen - Umsatz schlechter als erwartet | 1 | Investing.com Deutsch | ||
| 21.05. | Nexalin: $1.3 Million PONM Acquisition Expands AI-Integrated Neurostimulation Platform Ahead Of FDA Trial | 1 | pulse2.com | ||
| 21.05. | Nexalin Technology, Inc.: Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for ... | 3 | GlobeNewswire (USA) | ||
| 19.05. | Nexalin Technology, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 19.05. | Nexalin Technology, Inc.: Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO Clarity and Nexalin NeuroCare Ahead of Planned FDA Pivotal Trial | 563 | GlobeNewswire (Europe) | HOUSTON, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. ( (Nasdaq: NXL) ("Nexalin" or the "Company"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the... ► Artikel lesen |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORGANON | 11,840 | -0,34 % | Dividendenbekanntmachungen (14.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADM HAMBURG AG DE0007269003 - 13,58 EUR AGCO CORPORATION US0010841023 0,3 USD 0,2602 EUR AGNT INC US30212W1009 0,05 USD 0,0433... ► Artikel lesen | |
| QUIDELORTHO | 12,645 | 0,00 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| NANO-X IMAGING | 0,832 | +0,23 % | Nano-X Imaging Ltd: Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026 | ||
| PERSPECTIVE THERAPEUTICS | 2,726 | +2,02 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results | Advancing VMT-a-NET toward a Phase 3 study in neuroendocrine tumors, subject to regulatory alignment: regulatory engagement ongoing; clinical site activation targeted around year-end 2026 subject... ► Artikel lesen | |
| ROCKWELL MEDICAL | 8,170 | 0,00 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 0,870 | -2,12 % | Nuwellis, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 20,850 | +0,10 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NEURONETICS | 2,610 | +3,16 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| OPTIMIZERX | 7,950 | 0,00 % | OptimizeRx Corporation: OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth | The Company Names Andy D'Silva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027 Planned Transition Reflects Strong Succession Planning... ► Artikel lesen | |
| PULMONX | 2,140 | +3,88 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| OWLET | 4,965 | 0,00 % | Owlet: Hauptversammlung stimmt für Vergütungsplan und wählt Direktoren | ||
| PAVMED | 4,335 | +0,93 % | PAVmed Inc.: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results | Veris Health accelerated its commercial engagement with OSU-The James
Veris Health implantable physiological monitor achieved development milestones towards upcoming... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 8,000 | -1,23 % | Orthofix Medical Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| NEXGEL | 0,338 | -3,92 % | Celularity Inc.: Celularity Announces Closing of Transaction with NexGel | FLORHAM PARK, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company, today announced the closing of... ► Artikel lesen | |
| PICARD MEDICAL | 8,600 | 0,00 % | Why Is Picard Medical Stock Gaining Monday? |
NEXALIN TECHNOLOGY INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,000 (+0,04 %) liegt der Kurs bei 0,250 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXALIN TECHNOLOGY INC finden Sie auf Wallstreet Online.